Accurate assessment of the clinical relevance of a given BRCA1 variant is crucial for risk assessment, genetic counselling, and clinical management including cancer prevention in both the patient and healthy relatives with the same hereditary predisposition. This evidence concerns the gene BRCA1 and cancer.